Trump Should Not Go Soft on Pot

Reclassifying marijuana under federal rules would be a mistake — and isn’t necessary for further medical research.

Share this story

President Donald Trump speaks with the media on the day of the signing of an executive order to rename the Department of Defense the “Department of War”, in the Oval Office, at the White House in Washington, D.C., U.S., September 5, 2025.

Brian Snyder/Reuters

Today, Donald Trump will be in Queens to attend the men’s final for the U.S. Open. He’ll have to be luckier than many of the athletes competing in the tennis tournament to avoid the smell of marijuana. City Journal recounts that several of them have complained of a stench comparable to “Snoop Dogg’s living room,” as German tennis star Alexander Zverev put it.

Then again, if the skunky odor of weed mars Trump’s experience of the tournament, perhaps he will have second thoughts about relaxing the federal government’s restrictions on the drug. The Wall Street Journal reported last month that he was considering reclassifying pot as a Schedule III drug. He has yet to take this step. Emerging evidence about the many downsides of the mainstreaming of marijuana argues strongly against his doing so.

Jack Butler

About the Author

Jack Butler

Jack Butler is a former submissions editor at National Review.

Comments

Advertisement

Advertisement